For immunocytochemistry, fixed tissue must be cut in thin sections to be viewed in the light or fluorescence microscope.Rising prevalence of chronic diseases and cancers is one of the crucial factors driving demand for histopathology tests as a tissue pathology examination is of utmost importance for the diagnosis of a malignant tumor. Cancer is considered as one of the leading causes of death worldwide. Analysis of biopsy tissues enables pathologists to determine cancer type, stage, and the degree to which the disease has invaded healthy tissues.

Market Analysis and Insights: Global Tissue Sectioning Instrument Market
The global Tissue Sectioning Instrument market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Tissue Sectioning Instrument Scope and Market Size
The global Tissue Sectioning Instrument market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tissue Sectioning Instrument market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Rotary Microtome
Sliding Microtome
Ultramicrotome
Other

Segment by Application
Diagnosis
Research

The Tissue Sectioning Instrument market is analysed and market size information is provided by regions (countries). Segment by Application, the Tissue Sectioning Instrument market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Thermo Fisher Scientific
Leica Biosystems Nussloch GmbH
LLS ROWIAK LaserLabSolutions GmbH
Sakura Finetek Europe B.V.